Target Name: MLEC
NCBI ID: G9761
Other Name(s): MLEC_HUMAN | malectin | Malectin, transcript variant 1 | KIAA0152 | Malectin (isoform1 precursor) | Malectin | MLEC variant 1 | oligosaccharyltransferase complex subunit (non-catalytic)

MLEC: A Potential Drug Target and Biomarker

MLEC (MLEC-HUMAN) is a protein that is expressed in various tissues of the human body, including the nervous system, endothelial cells, and epithelial cells. It is a member of the MLEC (Mucin-Like Extracellular Matrix) family, which is Characterized by the presence of a secreted portion of the cell that is similar to mucin, a protein produced by glands and other epithelial cells.

MLEC has been shown to play a role in various physiological processes in the body, including cell signaling, migration, and invasion. It is also involved in the development and maintenance of tissues, including the placenta and the uropeptide transdermal absorption system.

MLEC has also been identified as a potential drug target, due to its involvement in various diseases and its ability to interact with certain signaling pathways. For example, MLEC has been shown to be involved in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. It is also thought to play a role in cancer, with studies showing that MLEC is often overexpressed in cancer cells.

In addition to its potential as a drug target, MLEC is also of interest as a biomarker for certain diseases. For example, MLEC has been shown to be elevated in the brains of individuals with Alzheimer's disease, and may be a useful diagnostic marker for this disease. Additionally, MLEC has been shown to be decreased in the blood of individuals with certain types of cancer, which may make it a useful indicator for the disease.

Overall, MLEC is a protein that has significant potential as a drug target and biomarker. Further research is needed to fully understand its role in various biological processes and its potential as a therapeutic agent.

Protein Name: Malectin

Functions: Carbohydrate-binding protein with a strong ligand preference for Glc2-N-glycan. May play a role in the early steps of protein N-glycosylation (By similarity)

More Common Targets

MLF1 | MLF1-DT | MLF2 | MLH1 | MLH3 | MLIP | MLIP-AS1 | MLKL | MLLT1 | MLLT10 | MLLT10P1 | MLLT11 | MLLT3 | MLLT6 | MLN | MLNR | MLPH | MLST8 | MLX | MLXIP | MLXIPL | MLYCD | MMAA | MMAB | MMACHC | MMADHC | MMADHC-DT | MMD | MMD2 | MME | MMEL1 | MMGT1 | MMP | MMP1 | MMP10 | MMP11 | MMP12 | MMP13 | MMP14 | MMP15 | MMP16 | MMP17 | MMP19 | MMP2 | MMP2-AS1 | MMP20 | MMP20-AS1 | MMP21 | MMP23A | MMP23B | MMP24 | MMP24-AS1-EDEM2 | MMP24OS | MMP25 | MMP25-AS1 | MMP26 | MMP27 | MMP28 | MMP3 | MMP7 | MMP8 | MMP9 | MMRN1 | MMRN2 | MMS19 | MMS22L | MMS22L-TONSL complex | MMUT | MMXD complex | MN1 | MNAT1 | MND1 | MNDA | MNS1 | MNT | MNX1 | MNX1-AS1 | MOAP1 | MOB1A | MOB1B | MOB2 | MOB3A | MOB3B | MOB3C | MOB4 | MOBP | MOCOS | MOCS1 | MOCS2 | MOCS2-DT | MOCS3 | MOG | MOGAT1 | MOGAT2 | MOGAT3 | MOGS | MOK | MON1A | MON1B | MON2